Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 74, Issue 3, Pages 452-462
Publisher
Wiley
Online
2018-10-17
DOI
10.1111/his.13772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
- (2018) Grace Kim et al. MODERN PATHOLOGY
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications
- (2017) Peter Rambau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
- (2017) Yu Zhao et al. Journal of Ovarian Research
- Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer
- (2016) Linda E. Kelemen et al. GYNECOLOGIC ONCOLOGY
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
- (2016) Mackenzie Coatham et al. MODERN PATHOLOGY
- CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
- (2016) Piero Dalerba et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early-Stage Endometrioid Ovarian Carcinoma
- (2014) Aalok Kumar et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
- (2013) Melissa K McConechy et al. MODERN PATHOLOGY
- Calculator for ovarian carcinoma subtype prediction
- (2010) Steve E Kalloger et al. MODERN PATHOLOGY
- Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
- (2009) Martin Köbel et al. GYNECOLOGIC ONCOLOGY
- Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules
- (2009) Yoji Wani HISTOPATHOLOGY
- Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2
- (2008) O Houghton et al. HISTOPATHOLOGY
- Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation
- (2008) Yoji Wani et al. HUMAN PATHOLOGY
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
- (2008) C. Blake Gilks et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now